Works by Khuntha, Sarayuth


Results: 7
    1
    2
    3
    4

    Onasemnogene Abeparvovec Gene Therapy and Risdiplam for the Treatment of Spinal Muscular Atrophy in Thailand: A Cost-Utility Analysis: A Cost-Utility Analysis of Onasemnogene Abeparvovec and Risdiplam for SMA Treatment: S. Khuntha et al.

    Published in:
    Applied Health Economics & Health Policy, 2025, v. 23, n. 2, p. 277, doi. 10.1007/s40258-024-00915-y
    By:
    • Khuntha, Sarayuth;
    • Prawjaeng, Juthamas;
    • Ponragdee, Kunnatee;
    • Sanmaneechai, Oranee;
    • Srinonprasert, Varalak;
    • Leelahavarong, Pattara
    Publication type:
    Article
    5
    6
    7

    Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis.

    Published in:
    Asian Pacific Journal of Allergy & Immunology, 2022, v. 40, n. 4, p. 321, doi. 10.12932/ap-121122-1501
    By:
    • Angkasekwinai, Nasikarn;
    • Prawjaeng, Juthamas;
    • Leelahavarong, Pattara;
    • Khuntha, Sarayuth;
    • Pheerapanyawaranun, Chatkamol;
    • Chitpim, Natthakan;
    • Srinonprasert, Varalak;
    • Chokephaibulkit, Kulkanya
    Publication type:
    Article